BridgeMD
Compares treatment options for PROSTATE CANCER
Official title Two-fraction Versus Five-fraction Stereotactic Radiotherapy for Localized Prostate Cancer
ClinicalTrials.gov ID: NCT06027892
What this study is testing
- What it's testing
- The goal of this clinical trial is to compare two dose schedules of stereotactic radiation therapy in patients with localized prostate cancer. Historically, external beam radiation to treat localized prostate cancer was given in small treatments over a period of multiple weeks.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, men only
You may be able to join if
- Inclusion:
- Male patients ≥18 years
- Diagnosis of low- or favorable intermediate-risk prostate adenocarcinoma
- T1-T2c
- Prostate specific antigen \< 20
See the full eligibility criteria
- Inclusion:
- Male patients ≥18 years
- Diagnosis of low- or favorable intermediate-risk prostate adenocarcinoma
- T1-T2c
- Prostate specific antigen \< 20
- Gleason 6 or 7 (3+4)
- Cannot had multiple intermediate-risk factors consistent with unfavorable intermediate risk disease
- Prostate gland \< 60 cc (can include following cytoreductive androgen deprivation)
- International Prostate Symptom Score \< 15 (unaided by a-adrenergic inhibitor or anticholinergic drugs) Exclusion:
- Unfavorable intermediate-risk disease and above
- Chronic inflammatory bowel condition (IBD, Crohn's disease, Sarcoidosis, Rheumatic disease)
- Chronic immunosuppression
- Contraindications to hydrogel spacer placement
- Contraindications to a prostate MRI
- Any prior prostate cancer treatment
- Prior pelvic radiotherapy
- Previous transurethral resection of the prostate (TURP) within 12 months
- Hip prosthesis
- Prior use of therapeutic androgen deprivation therapy
The study team makes the final eligibility decision.
Where it's taking place
- Petah Tikva, Israel, Israel
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Petah Tikva, Israel, Israel. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.